BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9376597)

  • 1. Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity.
    Ott MM; Bartkova J; Bartek J; Dürr A; Fischer L; Ott G; Müller-Hermelink HK; Kreipe H
    Blood; 1997 Oct; 90(8):3154-9. PubMed ID: 9376597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene.
    Swerdlow SH; Yang WI; Zukerberg LR; Harris NL; Arnold A; Williams ME
    Hum Pathol; 1995 Sep; 26(9):999-1004. PubMed ID: 7545645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1.
    Zukerberg LR; Benedict WF; Arnold A; Dyson N; Harlow E; Harris NL
    Blood; 1996 Jul; 88(1):268-76. PubMed ID: 8704183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved diagnostic segregation of mantle cell lymphoma by determination of cyclin D1/D3 expression ratio in formalin-fixed tissue.
    Mangseth K; Helgeland L; Klos J; Molven A; Vintermyr OK
    Diagn Mol Pathol; 2009 Sep; 18(3):150-5. PubMed ID: 19704260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
    de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
    Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements.
    Swerdlow SH; Zukerberg LR; Yang WI; Harris NL; Williams ME
    Am J Surg Pathol; 1996 May; 20(5):627-40. PubMed ID: 8619427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 protein expression in mantle cell lymphoma.
    Alkan S; Schnitzer B; Thompson JL; Moscinski LC; Ross CW
    Ann Oncol; 1995 Jul; 6(6):567-70. PubMed ID: 8573535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.
    Yang WI; Zukerberg LR; Motokura T; Arnold A; Harris NL
    Am J Pathol; 1994 Jul; 145(1):86-96. PubMed ID: 7518196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocation.
    Pruneri G; Fabris S; Fasani R; Del Curto B; Capella C; Pozzi B; Motta T; Andreola S; Ferreri AJ; Ponzoni M; Viale G; Neri A
    J Pathol; 2003 Aug; 200(5):596-601. PubMed ID: 12898595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma.
    Nakamura S; Seto M; Banno S; Suzuki S; Koshikawa T; Kitoh K; Kagami Y; Ogura M; Yatabe Y; Kojima M
    Jpn J Cancer Res; 1994 Dec; 85(12):1270-9. PubMed ID: 7531681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow.
    Vasef MA; Medeiros LJ; Koo C; McCourty A; Brynes RK
    Am J Clin Pathol; 1997 Sep; 108(3):302-7. PubMed ID: 9291459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of cyclin D1 mRNA by reverse transcription-polymerase chain reaction in paraffin-embedded tissues and its diagnostic significance for mantle cell lymphoma].
    Shui RH; Wei YK; Sun MH; Wang J; Shi DR; Zhang TM; Jin AP; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):514-8. PubMed ID: 16383299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of cyclin D2 in chronic B-cell malignancies.
    Delmer A; Ajchenbaum-Cymbalista F; Tang R; Ramond S; Faussat AM; Marie JP; Zittoun R
    Blood; 1995 May; 85(10):2870-6. PubMed ID: 7742549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma.
    Uchimaru K; Taniguchi T; Yoshikawa M; Asano S; Arnold A; Fujita T; Motokura T
    Blood; 1997 Feb; 89(3):965-74. PubMed ID: 9028328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry.
    Zukerberg LR; Yang WI; Arnold A; Harris NL
    Am J Clin Pathol; 1995 Jun; 103(6):756-60. PubMed ID: 7540362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.
    Metcalf RA; Zhao S; Anderson MW; Lu ZS; Galperin I; Marinelli RJ; Cherry AM; Lossos IS; Natkunam Y
    Mod Pathol; 2010 Mar; 23(3):420-33. PubMed ID: 20062012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
    Williams ME; Swerdlow SH
    Ann Oncol; 1994; 5 Suppl 1():71-3. PubMed ID: 8172823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma.
    Ott MM; Helbing A; Ott G; Bartek J; Fischer L; Dürr A; Kreipe H; Müller-Hermelink HK
    J Pathol; 1996 Jul; 179(3):238-42. PubMed ID: 8774476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases.
    Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY
    Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.